Latest News and Press Releases
Want to stay updated on the latest news?
-
Austin, May 18, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Personalized Cancer Vaccine Market was valued at USD 302 million in 2025 and is expected to reach USD 12.30 billion by 2035,...
-
Bitget today reported a 216% cumulative user growth* in Southeast Asia at its flagship Summer Camp 2026, h
-
WOODCLIFF LAKE, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) (“Hudson”; or “the Company”) a leading provider of innovative and sustainable refrigerant products and...
-
HOUSTON, May 18, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending focused on the...
-
REYNOLDSBURG, Ohio, May 18, 2026 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today issued a letter to shareholders highlighting the significant...
-
Board Unanimously Recommends Shareholders Vote “For” All Three Resolutions; Investor Update Video and Presentation Expected to Be Released on May 27, 2026 Dublin, Ireland, May 18, 2026 (GLOBE...
-
TORRANCE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), a leader in GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, will...
-
Integrates Ultra-Low Cost, Mass-Producible Long-Range Surveillance and One Way Systems into the Draganfly Platform of Drones Tampa, FL., May 18, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:...
-
Israeli Ministry of Health approved the initiation of Silexion's Phase 2/3 clinical trial of SIL204 in locally advanced pancreatic cancer Clinical Trial Application subsequently submitted to Germany...
-
TEL AVIV, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company's corporate...